|
|
Tercica,Inc News (NASDAQ:TRCA)
| Latest Tercica,Inc News Headlines | | Date | Time | Source | | | 10/19/2005 | 4:23PM | PRNUS | Tercica, Inc. to Release Third Quarter Financial Results on November 2
BRISBANE, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Tercica, Inc. (NASDAQ:TRCA) announced today that it will release its third quarter financial results on November 2, 2005 at 4:00 p.m. EST. The Company will also host a live conference call and webcast at 4:30 p.m. EST that same day.
To access the live teleconference... More...>> |
| 09/23/2005 | 9:00AM | PRNUS | Tercica Presents Three Scientific Posters at the ESPE/LWPES 7th Joint Meeting of Pediatric Endocrinology
LYON, France, Sept. 23 /PRNewswire-FirstCall/ -- Tercica, Inc. (NASDAQ:TRCA) today presented three scientific posters at the ESPE/LWPES 7th Joint Meeting of Pediatric Endocrinology in Lyon, France. These posters detail results including the first available data for six children who received Increlex(TM) (mecasermin... More...>> |
| 09/21/2005 | 1:30PM | PRNUS | Tercica Presents Three Posters at ESPE/LWPES 7th Joint Meeting of Pediatric Endocrinology
Company Also to Host Satellite Symposium on the New Science of Growth and Primary IGF-1 Deficiency
BRISBANE, Calif., Sept. 21 /PRNewswire-FirstCall/ -- Tercica, Inc. (NASDAQ:TRCA) today announced it will present new data for children with severe Primary IGFD who were treated with Increlex(TM) (rhIGF-1, mecasermin [rDNA... More...>> |
| 09/07/2005 | 9:02AM | PRNUS | Tercica, Inc. Announces Webcast of Corporate Presentation at the 12th Anniversary of the NewsMakers in the Biotech Industry Conf
BRISBANE, Calif., Sept. 7 /PRNewswire-FirstCall/ -- Tercica, Inc. (NASDAQ:TRCA) announced today that it will present at the upcoming 12th Anniversary of the NewsMakers in the Biotech Industry Conference. Tercica's presentation will begin at 3:20 p.m. EDT on Friday, September 9, 2005. To access the live webcast, please... More...>> |
| 08/31/2005 | 4:00AM | PRNUS | FDA Approves Tercica's Increlex for Short Stature Caused by Severe Primary IGF-1 Deficiency
- Targeted Replacement Therapy for Growth Failure in Children With Low Blood Levels of the Hormone IGF-1
BRISBANE, Calif., Aug. 31 /PRNewswire-FirstCall/ -- Tercica, Inc. (NASDAQ:TRCA) announced today that the U.S. Food and Drug Administration (FDA) has approved Increlex(TM) (mecasermin [rDNA origin] injection) for... More...>> |
| 08/24/2005 | 8:30AM | PRNUS | Tercica Submits Response to Citizen Petition
BRISBANE, Calif., Aug. 24 /PRNewswire-FirstCall/ -- Tercica, Inc. (NASDAQ:TRCA) announced today that it has submitted to the U.S. Food & Drug Administration a written response to Insmed Incorporated's Citizen Petition filed on August 11, 2005. Tercica's written response has been posted to its web site at: http://investor.tercica.com/... More...>> |
| 08/17/2005 | 4:07PM | PRNUS | Tercica Names Michael Astrue to Board of Directors
BRISBANE, Calif., Aug. 17 /PRNewswire-FirstCall/ -- Tercica, Inc. (NASDAQ:TRCA) announced today that it has named Michael Astrue to the company's board of directors.
"As a strategist and business leader in the biotech industry, and with his extensive orphan drug and regulatory experience, Michael is in a position to... More...>> |
| 08/17/2005 | 4:05PM | PRNUS | Tercica Addresses Citizen Petition Filed by Insmed
Company Refutes Competitor's Assertions
BRISBANE, Calif., Aug. 17 /PRNewswire-FirstCall/ -- Tercica, Inc. (NASDAQ:TRCA) today addressed Insmed Incorporated's citizen petition seeking to have the U.S. Food & Drug Administration deny approval of Tercica's New Drug Application for Increlex(TM). The company stated that... More...>> |
| 08/14/2005 | 5:58PM | PRNUS | Tercica Announces Insmed Files Citizen Petition with the FDA to Deny Approval of Increlex NDA
- Tercica to Host Conference Call at 9:00 a.m. EDT Tomorrow, August 15 to Discuss This Development -
BRISBANE, Calif., Aug. 14 /PRNewswire-FirstCall/ -- Tercica, Inc. (NASDAQ:TRCA) announced today that Insmed Incorporated has filed a Citizen Petition to immediately deny approval of Tercica's NDA for Increlex(TM). Upon... More...>> |
| 08/03/2005 | 4:05PM | PRNUS | Tercica Reports Second Quarter 2005 Financial Results
BRISBANE, Calif., Aug. 3 /PRNewswire-FirstCall/ -- Tercica, Inc. (NASDAQ:TRCA) announced today the results of operations for the quarter ended June 30, 2005. The net loss was $12.4 million for the second quarter of 2005 compared to a net loss of $11.4 million for the same period in 2004.
Basic and diluted net loss... More...>> |
| 07/20/2005 | 9:00AM | PRNUS | Tercica, Inc. to Release Second Quarter Financial Results on August 3
Tercica, Inc. to Release Second Quarter Financial Results on
August 3
SOUTH SAN FRANCISCO, Calif., July 20 /PRNewswire-FirstCall/ -- Tercica, Inc.
(NASDAQ:TRCA) announced today that it will release its second quarter financial
results on August 3, 2005 at 4:00 p.m. EDT. The Company will also host a live
conference... More...>> |
| 06/17/2005 | 9:00AM | PRNUS | Tercica Files Request to Withdraw Motion for a Preliminary Injunction Against Insmed and Celtrix
Tercica Files Request to Withdraw Motion for a Preliminary
Injunction Against Insmed and Celtrix
SOUTH SAN FRANCISCO, Calif., June 17 /PRNewswire-FirstCall/ -- Tercica, Inc.
(NASDAQ:TRCA) announced today that Tercica and its co-plaintiff, Genentech,
Inc., have filed a request to withdraw their motion for a preliminary
injunction... More...>> |
| 06/07/2005 | 9:00AM | PRNUS | Tercica Presents Two Pharmacokinetic Studies in an Oral Session at the 87th Annual Meeting of the Endocrine Society
Tercica Presents Two Pharmacokinetic Studies in an Oral Session
at the 87th Annual Meeting of the Endocrine Society
Human Studies Demonstrate That Administration of rhIGF-1 Alone Causes a Prompt
Increase in Blood IGFBP-3 Levels
SAN DIEGO, June 7 /PRNewswire-FirstCall/ -- Tercica, Inc. (NASDAQ:TRCA)
announced today that... More...>> |
| 06/06/2005 | 9:01AM | PRNUS | Tercica Presents Pharmacokinetic and Safety Data From Several Studies at the 87th Annual Meeting of the Endocrine Society
Tercica Presents Pharmacokinetic and Safety Data From Several
Studies at the 87th Annual Meeting of the Endocrine Society
--New Diagnostic Tools and Safety Studies Provide Further Evidence Supporting
rhIGF-1 as a Potential Therapy for Short Stature Due to Primary IGF-1
Deficiency--
SAN DIEGO, June 6 /PRNewswire-FirstCall/... More...>> |
| 06/02/2005 | 9:00AM | PRNUS | Tercica, Inc. Announces Webcast of Corporate Presentation at the Pacific Growth Equities Life Sciences Growth Conference
Tercica, Inc. Announces Webcast of Corporate Presentation at the
Pacific Growth Equities Life Sciences Growth Conference
SOUTH SAN FRANCISCO, Calif., June 2 /PRNewswire-FirstCall/ -- Tercica, Inc.
(NASDAQ:TRCA) announced today that it will present at the upcoming Pacific
Growth Equities Life Sciences Growth Conference... More...>> |
| 06/01/2005 | 9:01AM | PRNUS | Tercica Announces Five Presentations at the 87th Annual Meeting of the Endocrine Society
Tercica Announces Five Presentations at the 87th Annual Meeting
of the Endocrine Society
Tools for Diagnosing Primary IGF-1 Deficiency and New Safety, Pharmacokinetic,
and Diagnostic Data
SOUTH SAN FRANCISCO, Calif., June 1 /PRNewswire-FirstCall/ -- Tercica, Inc.
(NASDAQ:TRCA) announced today that it will present novel... More...>> |
| 05/31/2005 | 9:01AM | PRNUS | Tercica Files Preliminary Injunction Against Insmed and Celtrix
Tercica Files Preliminary Injunction Against Insmed and Celtrix
SOUTH SAN FRANCISCO, Calif., May 31 /PRNewswire-FirstCall/ -- Tercica, Inc.
(NASDAQ:TRCA) announced today that Tercica and its co-plaintiff, Genentech,
Inc., have filed a motion for a preliminary injunction against Insmed
Incorporated and Celtrix, Inc... More...>> |
| 05/27/2005 | 9:00AM | PRNUS | Tercica, Inc. Announces Webcast of Corporate Presentation at the Friedman, Billings, Ramsey & Co., Inc., 9th Annual Growth Inves
Tercica, Inc. Announces Webcast of Corporate Presentation at the
Friedman, Billings, Ramsey & Co., Inc., 9th Annual Growth Investor Conference
SOUTH SAN FRANCISCO, Calif., May 27 /PRNewswire-FirstCall/ -- Tercica, Inc.
(NASDAQ:TRCA) announced today that it will present at the upcoming Friedman,
Billings, Ramsey & Co... More...>> |
| 05/26/2005 | 9:00AM | PRNUS | Tercica Announces Management Changes
Tercica Announces Management Changes
SOUTH SAN FRANCISCO, Calif., May 26 /PRNewswire-FirstCall/ -- Tercica, Inc.
(NASDAQ:TRCA) announced today that Timothy P. Lynch, Chief Financial Officer,
has resigned from the company, effective June 10. Mr. Lynch is taking a
position as Chief Executive Officer of a venture-backed... More...>> |
| 05/23/2005 | 9:01AM | PRNUS | Tercica Announces Court Rulings in United Kingdom Regarding Patent Litigation Against Insmed and Avecia
Tercica Announces Court Rulings in United Kingdom Regarding
Patent Litigation Against Insmed and Avecia
- Insmed's Motions for Summary Judgment are Denied; Court Rules in Tercica's
and Genentech's Favor -
SOUTH SAN FRANCISCO, Calif., May 23 /PRNewswire-FirstCall/ -- Tercica, Inc.
(NASDAQ:TRCA) announced today that the... More...>> |
|
|
|